Allergios is proud to announce a public-private-partnership with Wageningen University & Research, supported by Health-Holland, Top Sector Life Sciences & Health. The objective of this partnership is to validate an innovative test for the diagnosis of food allergy, the GranulEye test.
Dr. ir. Janneke Ruinemans-Koerts (clinical chemist at Rijnstate Hospital/Dicoon laboratories and associate professor at Wageningen University & Research) will lead the analytical and clinical validation of the GranulEye for the diagnosis of peanut allergy. This in vitro diagnostic system measures the basophil activation by visualization of stimulated basophils by e.g. peanut allergen. This novel method of basophil activation measurement will be compared with the current methods of basophil activity analysis (Basophil Activation Test).
Current tests to diagnose allergy such as the skin prick test and the IgE blood tests, indicate sensitization to allergens, but not necessarily an allergic clinical response. The current gold standard, the double-blind placebo-controlled food challenge can induce severe allergic reactions, is burdensome for the patient, is time-consuming and costly. Allergios’ in vitro diagnostic test offers the promise of a clear, accurate test without these drawbacks.
Allergios, is gratified not only by the scientific collaboration with Wageningen University & Research but also by the support from Health-Holland. “We’ve always been excited by the science of our innovation, but ultimately we’re most excited by the interest of the clinicians and the impact it will bring to allergy sufferers. This partnership will bring us one step closer to having that impact. A more reliable test to diagnose an actual food allergy can be considered as a breakthrough.”
Powered by Health-Holland, Top Sector Life Sciences & Health.